Free Trial

Boston Trust Walden Corp Boosts Stock Holdings in Allegion PLC $ALLE

Allegion logo with Industrials background

Key Points

  • Boston Trust Walden Corp increased its stake in Allegion PLC by 9.9%, owning approximately 0.78% of the company, valued at $96.3 million.
  • Allegion reported $2.04 earnings per share for the last quarter, exceeding expectations, with a year-over-year revenue growth of 5.8%.
  • Allegion recently announced a quarterly dividend of $0.51, translating to an annual yield of 1.2%.
  • Five stocks we like better than Allegion.

Boston Trust Walden Corp grew its position in shares of Allegion PLC (NYSE:ALLE - Free Report) by 9.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 668,432 shares of the scientific and technical instruments company's stock after purchasing an additional 60,412 shares during the quarter. Boston Trust Walden Corp owned approximately 0.78% of Allegion worth $96,334,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Avantax Advisory Services Inc. increased its holdings in shares of Allegion by 1.8% during the 1st quarter. Avantax Advisory Services Inc. now owns 4,180 shares of the scientific and technical instruments company's stock valued at $545,000 after purchasing an additional 73 shares in the last quarter. Whittier Trust Co. grew its stake in Allegion by 16.6% in the 1st quarter. Whittier Trust Co. now owns 576 shares of the scientific and technical instruments company's stock valued at $75,000 after acquiring an additional 82 shares during the period. DMC Group LLC grew its stake in Allegion by 2.2% in the 1st quarter. DMC Group LLC now owns 3,953 shares of the scientific and technical instruments company's stock valued at $516,000 after acquiring an additional 85 shares during the period. Ethic Inc. grew its stake in Allegion by 1.2% in the 1st quarter. Ethic Inc. now owns 7,514 shares of the scientific and technical instruments company's stock valued at $984,000 after acquiring an additional 87 shares during the period. Finally, Rovin Capital UT ADV grew its stake in Allegion by 2.3% in the 1st quarter. Rovin Capital UT ADV now owns 4,215 shares of the scientific and technical instruments company's stock valued at $550,000 after acquiring an additional 96 shares during the period. 92.21% of the stock is owned by hedge funds and other institutional investors.

Allegion Trading Up 0.3%

Shares of ALLE stock opened at $173.78 on Tuesday. The company's 50-day moving average price is $172.26 and its 200-day moving average price is $151.94. The company has a current ratio of 2.30, a quick ratio of 1.64 and a debt-to-equity ratio of 1.14. The stock has a market cap of $14.92 billion, a price-to-earnings ratio of 24.14, a PEG ratio of 3.72 and a beta of 1.07. Allegion PLC has a twelve month low of $116.57 and a twelve month high of $180.34.

Allegion (NYSE:ALLE - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The scientific and technical instruments company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $2.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $999.10 million. Allegion had a net margin of 16.15% and a return on equity of 42.62%. The company's revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.96 EPS. Allegion has set its FY 2025 guidance at 8.000-8.150 EPS. As a group, equities analysts predict that Allegion PLC will post 7.77 earnings per share for the current year.

Allegion Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Monday, September 15th were issued a $0.51 dividend. This represents a $2.04 annualized dividend and a yield of 1.2%. The ex-dividend date was Monday, September 15th. Allegion's payout ratio is 28.33%.

Analyst Upgrades and Downgrades

ALLE has been the topic of a number of research analyst reports. Zacks Research cut shares of Allegion from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 28th. Morgan Stanley lifted their target price on shares of Allegion from $139.00 to $151.00 and gave the stock an "equal weight" rating in a research note on Friday, July 11th. JPMorgan Chase & Co. started coverage on shares of Allegion in a research note on Tuesday, June 24th. They set an "overweight" rating and a $170.00 target price on the stock. Barclays lifted their target price on shares of Allegion from $163.00 to $185.00 and gave the stock an "equal weight" rating in a research note on Wednesday, October 1st. Finally, Wells Fargo & Company lifted their target price on shares of Allegion from $175.00 to $185.00 and gave the stock an "equal weight" rating in a research note on Monday, October 6th. Three analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, Allegion has a consensus rating of "Hold" and an average target price of $174.25.

Get Our Latest Report on ALLE

Insider Activity

In related news, SVP Tracy L. Kemp sold 3,849 shares of the business's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $164.92, for a total value of $634,777.08. Following the sale, the senior vice president directly owned 8,773 shares in the company, valued at approximately $1,446,843.16. The trade was a 30.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Timothy P. Eckersley sold 10,810 shares of the business's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $164.76, for a total transaction of $1,781,055.60. Following the sale, the senior vice president owned 30,023 shares in the company, valued at $4,946,589.48. This trade represents a 26.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.23% of the stock is currently owned by insiders.

Allegion Company Profile

(Free Report)

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.

Featured Articles

Want to see what other hedge funds are holding ALLE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allegion PLC (NYSE:ALLE - Free Report).

Institutional Ownership by Quarter for Allegion (NYSE:ALLE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Allegion Right Now?

Before you consider Allegion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allegion wasn't on the list.

While Allegion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.